Spondyloarthritis in Familial Mediterranean Fever: a Cohort Study

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2022 Jun 18

PMID 35716180

Authors

Sevtap Acer Kasman

Mehmet Tuncay Duruoz

Affiliations

Soon will be listed here.

Abstract

Familial Mediterranean fever (FMF) and spondyloarthritis (SpA) may show several common signs. This study aimed to evaluate the frequency of SpA and its manifestations in FMF, the impact of SpA on FMF, and the associations of non-episodic findings (heel enthesitis, protracted arthritis, and sacroiliitis) with the FMF features. Demographic, clinical, imaging, and genetic data were retrieved from medical records of the patients with adult FMF. To identify patients who met the classification criteria for SpA, data including rheumatologic inquiry were recorded. Patients with SpA and those who did not meet the criteria were compared in terms of FMF features. Regression analyses were performed to determine the factors that were most associated with sacroiliitis, enthesitis, and protracted arthritis. Of the 283 patients with FMF, 74 (26.1%) met the SpA criteria (64 axial, 10 peripheral); and 65 (22.9%) patients had sacroiliitis, 27 (9.5%) protracted arthritis, and 61 (21.6%) heel enthesitis. Patients with SpA were older and had more FMF severity, and heel pain rate than those without; however, genetic features, CRP, resistance to colchicine, and heel enthesitis did not differ. A meaningful number of patients without SpA had also displayed heel enthesitis, protracted arthritis, inflammatory back pain, heel pain, family history of SpA, and elevated CRP. Age was found to be the main predictor of heel enthesitis and protracted arthritis was linked with FMF severity. A significant number of patients with FMF meet the peripheral SpA classification criteria as well as axial SpA. SpA and its shared manifestations with FMF may have an impact on FMF.

Citing Articles

Familial mediterranean fever in a patient with ankylosing spondylitis: could familial mediterranean fever explain a typical eight-year ankylosing spondylitis?.

Bolla E, Karamanakos A, Fragoulis G, Iliopoulos A Rheumatol Int. 2024; 44(12):3119-3125.

PMID: 39436422 DOI: 10.1007/s00296-024-05736-9.

Pivotal role of the synovioentheseal complex in the imaging of arthritis and rheumatic diseases.

Yildiz A, Aydingoz U Diagn Interv Radiol. 2024; 30(6):409-418.

PMID: 38856322 PMC: 11589525. DOI: 10.4274/dir.2024.242740.

Authors' response: Main article "Apical fibrosis was the most common incidental pulmonary finding in a familial Mediterranean fever cohort".

Acer Kasman S, Sen N, Tezcan M Clin Rheumatol. 2023; 42(5):1499.

PMID: 36977951 DOI: 10.1007/s10067-023-06590-z.

Importance of hematological markers in familial Mediterranean fever in terms of disease severity and amyloidosis.

Tezcan M, Acer Kasman S, Sen N, Osken S, Yilmaz-Oner S Rheumatol Int. 2023; 43(7):1313-1321.

PMID: 36879026 DOI: 10.1007/s00296-023-05290-w.

Apical fibrosis was the most common incidental pulmonary finding in a familial Mediterranean fever cohort.

Sen N, Acer Kasman S, Baysal T, Dizman R, Yilmaz-Oner S, Tezcan M Clin Rheumatol. 2023; 42(5):1363-1370.

PMID: 36725780 PMC: 9891658. DOI: 10.1007/s10067-023-06526-7.

References

Ben-Chetrit E, Levy M . Familial Mediterranean fever. Lancet. 1998; 351(9103):659-64. DOI: 10.1016/S0140-6736(97)09408-7. View

Grateau G, Duruoz M . Autoinflammatory conditions: when to suspect? How to treat?. Best Pract Res Clin Rheumatol. 2010; 24(3):401-11. DOI: 10.1016/j.berh.2009.12.009. View

Atas N, Armagan B, Bodakci E, Satis H, Sari A, Bilge N . Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study. Rheumatol Int. 2019; 40(1):41-48. DOI: 10.1007/s00296-019-04412-7. View

Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O . Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int. 2019; 40(1):57-64. DOI: 10.1007/s00296-019-04391-9. View

Langevitz P, Livneh A, Zemer D, Shemer J, Pras M . Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997; 27(2):67-72. DOI: 10.1016/s0049-0172(97)80007-8. View

Tufan A, Mercan R, Tezcan M, Kaya A, Bitik B, Ozturk M . Enthesopathy in patients with familial Mediterranean fever: increased prevalence in M694 V variant. Rheumatol Int. 2013; 33(8):1933-7. DOI: 10.1007/s00296-013-2669-4. View

Sen N, Yilmaz M, Mercan R, Volkan O, Yilmaz-Oner S, Tukel E . Enthesitis may be one of the signs of severe disease in familial Mediterranean fever. Clin Rheumatol. 2020; 40(4):1479-1485. DOI: 10.1007/s10067-020-05392-x. View

Kasifoglu T, Calisir C, Cansu D, Korkmaz C . The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2008; 28(1):41-6. DOI: 10.1007/s10067-008-0980-3. View

Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F . High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther. 2013; 15(1):R21. PMC: 3672706. DOI: 10.1186/ar4154. View

10.

Borman P, Gokoglu F, Tasbas O, Yilmaz M, Yorgancioglu Z . Familial Mediterranean fever-related spondyloarthropathy. Singapore Med J. 2009; 50(3):e116-9. View

11.

Yildiz M, Tunc S, Sahin M, Okudan B, Aydin O, Suslu H . Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up?. Rheumatol Int. 2005; 26(3):220-3. DOI: 10.1007/s00296-004-0555-9. View

12.

Yazici A, Ozdemir Isik O, Temiz Karadag D, Cefle A . Are there any clinical differences between ankylosing spondylitis patients and familial Mediterranean fever patients with ankylosing spondylitis?. Int J Clin Pract. 2020; 75(1):e13645. DOI: 10.1111/ijcp.13645. View

13.

Akkoc N, Gul A . Familial Mediterranean fever and seronegative arthritis. Curr Rheumatol Rep. 2011; 13(5):388-94. DOI: 10.1007/s11926-011-0191-9. View

14.

Eshed I, Rosman Y, Livneh A, Kedem R, Langevitz P, Ben-Zvi I . Exertional leg pain in familial Mediterranean fever: a manifestation of an underlying enthesopathy and a marker of more severe disease. Arthritis Rheumatol. 2014; 66(11):3221-6. DOI: 10.1002/art.38797. View

15.

Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J . The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68(6):777-83. DOI: 10.1136/ard.2009.108233. View

16.

Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou C . The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2010; 70(1):25-31. DOI: 10.1136/ard.2010.133645. View

17.

Yilmaz O, Kisacik B, Ozkan F, Guven G, Unlu E, Pehlivan Y . Does enthesopathy relate to M694V gene mutation in patients with Familial Mediterranean fever?. Clin Rheumatol. 2013; 32(11):1593-8. DOI: 10.1007/s10067-013-2316-1. View

18.

Migita K, Hisanaga S, Izumi Y, Kawahara C, Shigemitsu Y, Iwanaga N . Protracted arthritis in a Japanese patient with familial Mediterranean fever. Mod Rheumatol. 2015; 27(5):905-909. DOI: 10.3109/14397595.2015.1031722. View

19.

Bodur H, Yurdakul F, Cay H, Ucar U, Keskin Y, Sargin B . Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort. Rheumatol Int. 2019; 40(1):29-40. DOI: 10.1007/s00296-019-04443-0. View

20.

Ben-Zvi I, Livneh A . Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol. 2010; 7(2):105-12. DOI: 10.1038/nrrheum.2010.181. View